| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-10 | 2025-02-20 | 2024-02-22 | 2023-02-24 | 2022-02-25 | 2020-12-31 | 2019-12-31 |
| Revenue | 180.9 | 178.7 | 175.2 | 168.8 | 165 | 120.4 | 97.35 |
| Cost of Revenue | 53.96 | 59.61 | 62.94 | 61.87 | 62.31 | 47.66 | 35.62 |
| Gross Profit | 127 | 119.1 | 112.2 | 106.9 | 102.7 | 72.78 | 61.73 |
| Operating Expenses | 135.8 | 143.2 | 150.9 | 163.3 | 135.4 | 81.26 | 64.51 |
| Research & Development | 48.11 | 49.43 | 52.4 | 57.39 | 48.38 | 29.57 | 24.22 |
| Selling, General and Administrative | 87.68 | 93.78 | 97.52 | 104.7 | 85.28 | 51.7 | 40.29 |
| Other Operating Expenses | 0 | 0 | 0.973 | 1.24 | 1.72 | 0 | 0 |
| Operating Income | -8.83 | -24.1 | -38.66 | -56.38 | -32.67 | -8.49 | -2.78 |
| Net Non-Operating Interest | -4.1 | 0.259 | 0.231 | -2.29 | -20.11 | -4.55 | -4.6 |
| Interest Income | 2.54 | 3.35 | 3.94 | 0.962 | 0 | 0.018 | 0.133 |
| Interest Expense | 6.64 | 3.1 | 3.7 | 3.25 | 20.11 | 4.57 | 4.73 |
| Equity & Other Income/(Expense) | 2.22 | 0.175 | 0.969 | -1.96 | 0 | -42.17 | -6.59 |
| Income Before Tax | -10.71 | -23.66 | -37.45 | -60.63 | -52.78 | -55.21 | -13.97 |
| Income Tax Expense | 2.13 | 7.65 | 8.91 | 7.87 | 6.57 | 3.55 | 1.6 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -12.85 | -31.32 | -46.37 | -68.5 | -59.35 | -58.76 | -15.57 |
| Depreciation and Amortization | 4.61 | 5.06 | 4.72 | 2.71 | 2.41 | 7.68 | 4.49 |
| EBITDA | -4.21 | -19.04 | -33.94 | -53.67 | -30.26 | -0.812 | 1.71 |
| Earnings Per Share (EPS) | -0.064 | -0.21 | -0.34 | -0.53 | -0.95 | -0.47 | -0.12 |
| Diluted Earnings Per Share | -0.064 | -0.21 | -0.34 | -0.53 | -0.95 | -0.47 | -0.12 |
| Weighted Average Shares Outstanding | 154.8 | 147.9 | 138.2 | 130.4 | 71.07 | 126.3 | 126.3 |
| Diluted Weighted Average Shares Outstanding | 154.8 | 147.9 | 138.2 | 130.4 | 71.07 | 126.3 | 126.3 |
